What research-use-only labeling does and does not mean

The FDA's Research Use Only label is a diagnostics rule, not a peptide rule

The specific regulation many sellers are borrowing this phrase from is 21 CFR 809.10(c)(2), part of FDA's labeling rules for in vitro diagnostic products, meaning devices used to run tests on patient samples. That rule lets a diagnostic product skip full clearance while it's still in the research phase of development, on the condition that it isn't represented as an effective diagnostic and carries the exact statement "For Research Use Only. Not for use in diagnostic procedures."

A peptide sold to an individual is not an in vitro diagnostic device, so this specific regulation doesn't actually govern it. When a peptide seller prints "Research Use Only. Not for human consumption." on a vial, it's borrowing the shape of a diagnostics rule, not operating under it.

What actually governs a peptide sold this way

FDA's real authority here comes from a broader source: the Federal Food, Drug, and Cosmetic Act's definition of a drug, which turns on intended use, not on the label alone. A product intended to treat, cure, prevent, or affect the structure or function of the human body is a drug under that Act, and an unapproved drug can't lawfully be sold for that use, whatever the package says.

FDA can point to a product's marketing copy, its written description, or even accessories sold alongside it, such as bacteriostatic water for reconstitution, as evidence of an intended human use that sits alongside, or contradicts, a "research use only" disclaimer.

FDA has said this in writing, repeatedly

This isn't a theoretical reading of the law. It's the exact basis FDA used in an August 2026 warning letter to Peak Performance Peptides: “Despite statements on your product labeling marketing your products for 'research use only' and 'not for human consumption,' evidence obtained from your website establishes that your products are intended to be drugs for human use.”

A warning letter to Wholesale Peptide the same year rejected an identical disclaimer over products including Gonadorelin and a compound marketed as "Prostamax," on the same theory: labeling something research-use-only doesn't change what a company's own marketing says the product is for.

These weren't isolated. A law firm that tracks FDA enforcement, Health Law Alliance, counted more than fifty warning letters issued to peptide and compounded GLP-1 sellers in September 2025 alone, over the same gap between an RUO label and marketing aimed at human use.

What this means for a buyer

This page states what FDA has done and said; it isn't legal advice, and whether a specific purchase or use is lawful depends on your own situation and jurisdiction. What the pattern above does show is that an RUO label is not a guarantee of anything, for the seller or for you. FDA has repeatedly treated it as beside the point once a company's own marketing shows the product is meant for a person to use.

It's also why this site doesn't give dosing, administration, or usage guidance for any product it reviews. We score what vendors document about their peptides, not whether or how to use them. That includes tirzepatide, semaglutide and the rest of the dual and triple agonist family: pharmaceutical approval and research-use-only labeling are two different questions, and this guide is about the second one.